Boxed warning thyroid C-cell tumors: GLP-1-based medications (including semaglutide, tirzepatide, and orforglipron) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies
Current offerings may include compounded Semaglutide injections, Tirzepatide options, oral GLP-1 drops, microdosing, branded medication options, provider visits, labs when included, and medication delivery, depending on the plan
19 In the study, the researchers used a large electronic health record database to conduct a nationwide retrospective cohort study to assess the association of semaglutide with the incidence and recurrence of suicidal ideation compared with non-GLP1R agonist anti-obesity medications in individuals with overweight or obesity
Helps patients find supply There is an incredible community forming online of patients trying to help other patients find medication
References: Chen X, et al